Skip to content

Homoeopathic treatment of premenstrual syndrome.

A comparative study on the effectiveness of individualised homeopathic medicine in centisimal versus LM potency in the management of premenstrual syndrome with its miasmatic analysis : a prospective open - label double - arm interventional study. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/02/103783
Enrollment
60
Registered
2026-02-12
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N943- Premenstrual tension syndrome

Interventions

Intervention1: Individualised Homoeopathic medicine in LM potency.: Patient qualifying to inclusion criteria will be taken into study. After proper case taking, analysis and evaluation will be done wi

Sponsors

Km Mantasha Aslam
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient with age group 18yrs to 45yrs having symptoms of PMS for more than 3 months. Patients having regular menstrual cycle. Patients fulfilling premenstrual screening criteria. Patients who can give informed consent and comply with study procedure.

Exclusion criteria

Exclusion criteria: Patient suffering from psychiatric disease. Patient suffering from known chronic systemic illness eg epilepsy, digestive, cardiovascular, renal and endocrine disorders. Patient taking hormonal pills. Pregnant, lactating and menopausal females. Patient suffering from PMDD. Patient having abnormal USG finding eg endometriosis, that can mimic PMS. Patient with age group less than 18yrs and greater than 45 yrs.

Design outcomes

Primary

MeasureTime frame
Primary outcome assessment will be done using Premenstrual syndrome scale.Timepoint: Primary outcome will be assessed using premenstrual syndrome scale at the interval of 3 months.

Secondary

MeasureTime frame
Secondary outcome assessment will be done using The short form 12 health survey (SF-12).Timepoint: Secondary outcome will be assessed using SF-12 at the interval of 3 months.

Countries

India

Contacts

Public ContactKm Mantasha Aslam

State National Homoepathic Medical College and Hospital

drshashiarya2105@gmail.com9450417584

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026